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During March and April 2002, a resurgence of Vibrio
cholerae O139 occurred in Dhaka and adjoining areas of
Bangladesh with an estimated 30,000 cases of cholera.
Patients infected with O139 strains were much older than
those infected with O1 strains (p<0.001). The reemerged
O139 strains belong to a single ribotype corresponding to
one of two ribotypes that caused the initial O139 outbreak
in 1993. Unlike the strains of 1993, the recent strains are
susceptible to trimethoprim, sulphamethoxazole, and strep-
tomycin but resistant to nalidixic acid. The new O139
strains carry a copy of the Calcutta type CTXCalc prophage
in addition to the CTXET prophage carried by the previous
strains. Thus, the O139 strains continue to evolve, and the
adult population continues to be more susceptible to O139
cholera, which suggests a lack of adequate immunity
against this serogroup. These findings emphasize the need
for continuous monitoring of the new epidemic strains.
V
ibrio cholerae O139 Bengal first emerged during 1992
and 1993 and caused large epidemics of cholera in
Bangladesh, India, and neighboring countries (1–3). This
new strain initially displaced the existing V. cholerae O1
strains. During 1994 to the middle of 1995, in most north-
ern and central areas of Bangladesh, the O139 vibrios were
replaced by a new clone of V. cholerae O1 of the El Tor
biotype, whereas in the southern coastal regions the O139
vibrios continued to exist (4–6). During late 1995 and
1996, cases of cholera attributable to both V. cholerae O1
and O139 were again detected in various regions of
Bangladesh. Since 1996, cholera in Bangladesh has been
caused mostly by V. cholerae O1 of the El Tor biotype;
only a few cases have been attributable to O139 serogroup
strains. The epidemiology of cholera in Bangladesh
changed again recently, and a large outbreak of cholera
caused predominantly by V. cholerae O139 occurred in the
capital city Dhaka and adjoining areas. 
From early March to the end of April 2002, approxi-
mately 2,350 cholera patients associated with V. cholerae
O139 were admitted to the Dhaka Hospital of the
International Centre for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B). A preliminary estimate showed
that >30,000 cases of cholera occurred in Dhaka and the
adjoining areas during this outbreak (A.S.G. Faruque,
unpub. data). Since the initial emergence of V. cholerae
O139 in 1992, we have monitored cholera outbreaks
caused by this serogroup in Bangladesh and neighboring
regions and have conducted several studies to characterize
O139 strains. These studies indicate that strains of the
O139 serogroup are undergoing rapid genetic changes,
resulting in the origination of new clones; at least seven
different ribotypes of O139 vibrios have been documented
(6–8). Furthermore, O139 vibrios may have originated
from more than one progenitor strain (8). The transient dis-
appearance and reemergence of V. cholerae O139 in
Bangladesh have raised questions regarding the origin of
the reemerged O139 vibrios. In this study, we examined
the current epidemiology of cholera in Bangladesh and
analyzed V. cholerae O139 isolated from the recent out-
break to investigate the origin of the recent epidemic
strains as well as to characterize possible genetic changes
in O139 vibrios that might have contributed to the recent
resurgence of V. cholerae O139. 
Materials and Methods
Clinical Surveillance
ICDDR,B maintains a 2% surveillance system at its
Dhaka Hospital, in which data from every 50th patient
treated at the hospital is collected; these data include clin-
ical information and biologic specimens. We used these
data to extrapolate the overall numbers of patients with
cholera; specimens from these patients were used in the
bacteriologic studies described.
V. cholerae Strains 
A total of 63 V. cholerae O139 isolates obtained from
the recent cholera epidemic were analyzed. Seven strains
of O139 vibrios isolated in India between 1992 and 1996,
17 strains of V. cholerae O139 isolated in Bangladesh
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in 1998 were also included in the study for comparison
with the recent epidemic strains. Strains of the recent epi-
demic were isolated from stools of cholera patients who
attended the treatment center of ICDDR,B located in
Dhaka during March and April 2002. Stool samples were
processed in the laboratory within 2 h of collection for the
isolation of V. cholerae. Stools were initially streaked on
thiosulphate-citrate-bile-sucrose (Becton, Dickinson and
Co., Sparks, MD) agar plates for selection and presump-
tive identification of V. cholerae. All strains were subse-
quently examined by biochemical and serologic tests using
standard methods (9). Strains were stored in sealed deep
nutrient agar at room temperature until used for this study.
Details of the strains are shown in Table. 
Polymerase Chain Reaction (PCR) Assays 
Presence of tcpA genes specific for the classical and El
Tor biotypes was determined by using a multiplex PCR
assay, as described previously (10). PCR assays for the
tcpI and acfB genes have been described previously (6).
Presence of classical, El Tor, and Calcutta type rstR genes
of CTX phage were also determined with PCR by using
specific primers derived from the published sequence of
the respective genes. Three different forward primers for
rstRclass, rstRET, and rstRCalc with sequences 5'-CTTCT-
CATCAGCAAAGCCTCCATC, 5'-GCACCATGATT-
TAAGATGCTC, and 5'-CTGTAAATCTCTTCAATCC-
TAGG, respectively, were used with a common reverse
primer (5'-TCGAGTTGTAATTCATCAAGAGTG) to
amplify the respective rstR genes. Presence of the rstC
gene was also determined by a PCR assay described previ-
ously (11). All primers were synthesized commercially by
Oswel DNAService (University of Edinburgh, Edinburgh,
UK). The expected sizes of the amplicons were ascertained
by electrophoresis in agarose gels, and the identity of each
PCR product was further verified by Southern blot
hybridization.
Probes and Hybridization 
The gene probes used in this study included a 0.5 kb
EcoRI fragment of pCVD27 (12) containing part of the
ctxA gene and a 2.1 kb SphI-XbaI fragment of pCTX-Km
containing the entire zot and ace genes and part of orfU
(13). The toxR gene probe was a 2.4-kb BamHI fragment
of pVM7 (14). The rstRET probe was a SacI-XbaI fragment
of pHK1 (15). The rRNA gene probe was a 7.5-kb BamHI
fragment of the Escherichia coli rRNA clone pKK3535
described previously (16). The O139-specific DNA probe
2R3 was a 1.3-kb EcoRI fragment of pCRII-A3 (17,18),
and the SXT probe was a NotI fragment of pSXT1 (19).
PCR-generated amplicons of the rstR genes of classical, El
Tor, or Calcutta type CTX prophage were also used as
probes whenever appropriate. 
For preparation of Southern blots, total cellular DNA
was isolated from overnight cultures as described previ-
ously (20). Five-microgram aliquots of the DNA were
digested with appropriate restriction enzymes (Bethesda
Research Laboratories, Gaithersburg, MD), elec-
trophoresed in 0.8% agarose gels, blotted onto nylon mem-
branes (Hybond, Amersham Biosciences, Uppsala,
Sweden), and processed by using standard methods
(21,22). The probes were labeled by random priming (23)
using a DNA labeling kit (Bethesda Research
Laboratories) and α-32P-deoxycytidine triphosphate (3,000
Ci/mmol, Amersham Biosciences). Southern blots were
hybridized with the labeled probes at 68°C and washed
under stringent conditions as described previously (6,8).
Emerging Infectious Diseases • Vol. 9, No. 9, September 2003 1117
RESEARCH 
Table. Comparative analysis of 63 Vibrio cholerae O139 strains isolated from a recent epidemic in Bangladesh versus O139 strains 
isolated between 1993 and 1998 in different countries 
Presence of genes
b 
Y of isolation 
 
Country 
No. of 
isolates 
 
Ribotype
a  rstR
ET  rstR
Clas  rstR
Cal  rstC 
STX 
genotype
a  Antibiogram
c 
1993  Bangladesh  5  B-I  +  -  -  +  A  S
R, SXT
R 
1993  Bangladesh  1  B-II  +  -  -  +  B  S
R, SXT
R 
1993–1995  Bangladesh  5  B-II  +  -  -  +  A  S
R, SXT
R 
1997  Bangladesh  3  B-II  +  -  -  +  C  Susceptible
b 
1997  Bangladesh  3  B-III  +  -  -  +  C  Susceptible
b 
1992  India  3  B-I  +  -  -  +  A  S
R, SXT
R 
1993  India  1  B-V  +  -  -  +  A  A
R, S
R, SXT
R 
1994  India  1  B-IV  +  -  -  +  A  S
R, SXT
R 
1996  India  2  B-II  +  -  -  +  A  A
R, Fz
R, S
R, SXT
R 
1998  Thailand  2  B-I  +  -  -  +  A  S
R, SXT
R 
2002  Bangladesh  63  B-II  +  -  +  +  C  Nal
R 
a Ribotypes and SXT genotypes are based on BglI restriction patterns of the respective genes and their flanking chromosomal sequence.  
bAll strains were positive for tcpA, tcpI, acfB, toxT, ctxA, zot, and ToxR genes as well as for the O139-specific genomic DNA in DNA probe or polymerase chain reaction 
assays.  
cAll strains were susceptible to tetracycline, ampicillin, chloramphenicol, gentamicin, ciprofloxacin, norfloxacin, nalidixic acid, streptomycin, trimethoprim, and 
sulfamethoxazole. Autoradiographs were developed from the hybridized fil-
ters with Kodak X-Omat AR x-ray film (Eastman Kodak
Co., Rochester, NY) at -70°C.
Antimicrobial Resistance 
All V. cholerae isolates were tested for resistance to
antimicrobial drugs by using the method of Bauer et al.
(24) with standard antibiotic disks (Oxoid Ltd.,
Basingstoke, Hampshire, UK) at the following antibiotic
concentrations (mg/disc): ampicillin, 10; chloramphenicol,
30; streptomycin, 10; tetracycline, 30; trimethoprim and
sulfamethoxazole, 1.25 and 23.75, respectively;
kanamycin, 30; gentamicin, 10; ciprofloxcin 5; nor-
floxacin 10, and nalidixic acid, 30. 
Results 
Clinical Surveillance 
We noted a marked increase in cholera cases associated
with V. cholerae O139 from March to May 2002 (Figure
1). The highest number of cholera patients admitted to the
hospital was in March; 69.8% of these cases were attrib-
uted to V. cholerae O139, compared to 30.2% of cases
caused by the El Tor biotype of V. cholerae O1. Cholera
attributable to V. cholerae O139 occurred with similar fre-
quencies in men and women, similar to those infected with
O1 strains. From January 2001 to June 2002, a total of 91
(32%) of 282 of case-patients infected with O1 cholera
were <5 years of age, but 15 (15%) of 115 of those infect-
ed with O139 were <5 years of age (p<0.001). During the
same period, 48% of those infected with V. cholerae O1
were >15 years of age, while 76% of those infected with
O139 were >15 years of age (p<0.001). 
Genetic Analysis of V. cholerae Strains 
The rRNA gene restriction patterns using BglI consist-
ed of 10 to 14 bands between 11 kb and 1.6 kb in size
(Figure 2). The 89 analyzed strains belonged to four differ-
ent ribotypes (B-I to B-IV). All 63 recently isolated O139
strains produced identical restriction patterns of their
rRNAgenes and belonged to ribotype B-II. Analysis of the
rstR gene showed that O139 strains isolated from 1992 to
1998 carried El Tor type CTXET prophage, whereas the
recent epidemic strains carry the Calcutta type CTXCalc
prophage in addition to the CTXET prophage (Figure 3).
All strains were positive for tcpA, tcpI, acfB, toxT, ctxA,
zot, and ToxR genes, as well as for the O139-specific
genomic DNA in DNA probe or PCR assays. 
Antibiogram 
All strains isolated from the recent epidemic were
resistant to nalidixic acid and were susceptible to ampi-
cillin, tetracycline, gentamicin, chloramphenicol, cipro-
floxacin, norfloxacin, streptomycin, trimethoprim, and sul-
famethoxazole. In these strains, the SXT element, which
encodes resistance to streptomycin, sulfamethoxazole, and
trimethoprim, carried a deletion of an approximately 3.6-
kb region.
Discussion
Generally, a seasonality exists in the cholera cases seen
at the ICDDR,B hospital, with increased numbers expect-
ed before and after the rainy season. Thus, the increase in
total number of cases seen during March and April was not
unusual (Figure 1). However, the increase in patient num-
bers during these months of 2002 was associated with a
marked increase in cases associated with V. cholerae
O139, and the numbers of cases infected with serogroup
O139 outnumbered those with serogroup O1. The ages of
patients infected with O139 strains were significantly
higher than those infected with O1 strains (p<0.001). Since
the onset of O139 cholera in 1992, this organism has tend-
ed to infect patients older than those with O1 cholera (1).
The more advanced age of this group was explained by a
lack of immunity to this new serogroup in adults who were
likely partially immune to the O1 serogroup. Thus, after
nearly 10 years of endemicity in Bangladesh, V. cholerae
O139 continues to cause more cases of cholera in older
adults. 
Ribotype Analysis
The emergence of the O139 serogroup has provided a
unique opportunity to witness the epidemiologic changes
associated with the displacement of an existing serogroup
by a new emerging one and thus provides new insights into
the epidemiology of the disease. All 63 recently isolated
O139 strains produced the identical restriction pattern of
their rRNA genes. This restriction pattern has been previ-
ously designated as ribotype pattern B-II (6–8) and was
first detected among epidemic V. cholerae O139 strains
that emerged in 1992 and 1993. Cholera epidemics during
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Figure 1. Numbers of diarrhea patients with cholera attributed to
Vibrio cholerae O1 and O139 from January 2001 to June 2002.
Those positive for cholera are extrapolated from a 2% sample of
all patients receiving treatment.1992 to 1993 in India and Bangladesh that were associat-
ed with the first appearance of V. cholerae O139 were
caused by strains belonging to two different ribotypes, des-
ignated as B-I and B-II. Since then, several new ribotypes
of O139 vibrios have been detected which were associated
with localized outbreaks during 1995 to 1996 or sporadic
cases (8). The results suggest that strains of the recent epi-
demic were clonal and were derived from one of the initial
clones of V. cholerae O139. We therefore investigated pos-
sible genetic changes sustained by this strain during the
nearly 9 years since major epidemics were caused by
strains of this ribotype. 
Analysis of CTX Prophage 
In  V. cholerae, the genes encoding cholera toxin
(ctxAB) are part of the CTX prophage (25). A typical
CTXF genome has two regions: core and the RS2. The 4.5-
kb core region comprises several open reading frames
including ctxAB, zot, ace, orfU, and encodes CT as well as
the functions that are required for the virion morphogene-
sis; by contrast, the 2.5-kb RS2 region encodes the regula-
tion, replication, and integration functions of the CTXF
genome (26). Previous studies have described the exis-
tence of at least three widely diverse repressor genes (rstR
genes) carried by different CTX phages (i.e., CTXETF,
CTXclassF, and CTXCalcF) (27,28). This diversity of rstR
constitutes the molecular basis for heteroimmunity among
CTX phages, which are otherwise genetically similar. We
examined the CTX prophage in the recent and previously
isolated O139 strains with specific probes. Analysis of the
rstR gene carried by the recent epidemic strains showed
that, unlike the O139 strains of 1993, which carried multi-
ple copies of an El Tor type CTXET prophage, the new
O139 strains carry at least one copy of the Calcutta type
CTXCalc prophage in addition to the CTXET prophage. As a
result of heteroimmunity, toxigenic classical strains of V.
cholerae O1 are known to be infected by CTXF isolated
from El Tor biotype strains; toxigenic El Tor strains are
resistant to further infection by the same phage. Similarly,
strains carrying an El Tor type CTX prophage can be
superinfected by the Calcutta type CTX phage (29).
Therefore, the new epidemic strains appear to have arisen
by acquisition of a Calcutta type CTX phage by strains that
originally harbored only El Tor type CTX prophage, since
the new strains carry both prophages (Figure 3). What
determines the reemergence of particular epidemic strains
is not clear, but this study clearly shows changes in the
CTX genotype attributed to the acquisition of a new CTX
phage by the O139 strains associated with the recent epi-
demic. 
Antibiogram of Reemergent O139 Strains 
V. cholerae O139, which emerged during 1992 and
1993, was sensitive to tetracycline and showed a trend of
increased resistance to trimethoprim-sulfamethoxazole
(SXT) and streptomycin. This resistance was mediated by
a ~99-kb self-transmissible transposon-like element (SXT
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Figure 2. Southern hybridization analysis of rRNA genes in Vibrio
cholerae O139 strains isolated from the recent epidemic and com-
parison with representative O139 strains isolated between 1992
and 1998. Genomic DNA was digested with BglI and probed with
a 7.5-kb BamHI fragment of the Escherichia coli rRNA clone
pKK3535. Lanes 1–6 represent O139 strains isolated from 1992 to
1998; lanes 6–12 represent O139 strains isolated from the recent
epidemic in Bangladesh. Designated ribotypes corresponding to
each restriction pattern are shown on top of the corresponding
lane. Numbers indicating molecular sizes of bands correspond to
1-kb DNA ladder (Bethesda Research Laboratories, Bethesda,
MD) used as molecular size markers.
Figure 3. Southern hybridization analysis of rstR genes in toxi-
genic Vibrio cholerae O139 strains isolated from the recent epi-
demic in Bangladesh (lanes 5–9) and in previously isolated O139
strains from 1992 to 1998 (lanes 1–4). Genomic DNA was digest-
ed with BglI and probed with the rstRET probe (A) and with the
rstRCal probe (B). Numbers indicating molecular sizes of bands
correspond to 1-kb DNA ladder (BRL) used as molecular size
markers.constin) encoding resistance to sulfamethoxazole,
trimethoprim, and streptomycin, the resistance genes being
clustered together in a 9.4-kb region (19). In the present
study, all strains isolated from the recent epidemic were
found to be susceptible to SXT and streptomycin (Table).
To identify the genetic changes associated with the
observed SXT sensitivity, we used a cloned SXT gene
probe to study restriction fragment length polymorphism
in the SXT transposon. Three different BglI restriction pat-
terns (patterns A–C) of the SXT element were observed
among the O139 strains tested (Figure 4). Strains produc-
ing pattern A and B were resistant to SXT and strepto-
mycin and included strains isolated between 1992 and
1996, whereas all strains from the recent epidemic pro-
duced pattern C and were susceptible to all the three antibi-
otics. Further analysis of the restriction patterns suggests
that the restriction site heterogeneity possibly occurred as
a result of a deletion of approximately a 3.6-kb region of
the SXT element in strains that were sensitive to SXT and
streptomycin. The deletion in the SXT element associated
with sensitivity to SXT and streptomycin was first detect-
ed in strains of ribotype B-III isolated from an outbreak in
Bangladesh in 1997 (6). In keeping with the observation in
Bangladesh, comparison of the antibiotic resistance pat-
terns between the O139 strains isolated during 1992 and
1993 and those isolated in 1996 and 1997 in India also
showed that the later strains were susceptible to SXT,
unlike the O139 strains from 1992 and 1993 (30).
However, in contrast to the previously isolated O139
strains, all O139 strains isolated from the recent epidemic
were resistant to nalidixic acid. 
Epidemiologic Importance of Genetic 
Changes in V. cholerae O139 
Several previous studies have shown that the O139
serogroup of V. cholerae has been undergoing rapid genet-
ic changes (6–8) since its first emergence. We speculate
that the observed changes may have provided increased fit-
ness to strains of this serogroup in some unexplained way
to survive in competition with the existing seventh pan-
demic strain of V. cholerae O1 and establish itself as the
etiologic agent of a possible eighth pandemic. The tran-
sient disappearance of the O139 serogroup in Bangladesh
and repeated reemergence associated with somewhat
altered genetic or phenotypic properties seem to support
this speculation. Our study demonstrated the reemergence
of  V. cholerae O139 strains belonging to a previously
described ribotype which has sustained at least three major
genetic and phenotypic changes. These changes include
the acquisition of a new CTX prophage, deletion in the
SXT element associated with reversion of drug resistance
phenotype against SXT and streptomycin, and develop-
ment of nalidixic acid resistance. 
The recent epidemic strains were otherwise similar to
previously described O139 strains, including possession of
the TCPpathogenicity island, as evidenced by the presence
of  tcpA,  tcpI, and acfB genes; the virulence regulatory
genes,  toxT and  toxR; and the O139–serotype-specific
DNA. The role of environmental and host factors that con-
tribute to the emergence of new strains associated with epi-
demic outbreaks is not clearly known. In the present study,
all strains isolated from the recent cholera outbreak
belonged to the same ribotype and were genetically and
phenotypically identical, suggesting that the recent out-
break in Bangladesh probably started from a point source
and may have coincided with the acquisition of one or
more critical new properties by a previously existing V.
cholerae O139 strain. Clearly these properties included the
acquisition of the Calcutta Type CTX prophage. Previous
studies showed that O139 strains prevailing in Calcutta
during 1996 carried this prophage (29,31,32), which might
have contributed to the dissimilar incidence of O139
cholera in Calcutta and Dhaka during that period (33).
How the initial enrichment of V. cholerae occurred before
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Figure 4. Analysis of SXT element in V. cholerae O139 strains iso-
lated isolated from the recent epidemic in Bangladesh (lanes 5–9)
and in previously isolated O139 strains between 1992 and 1998
(lanes 1–4). Genomic DNAwas digested with BglI and probed with
the SXT gene probe. Lanes 1, 2, and 4 show restriction pattern
corresponding to SXT genotype A, lane 3 shows SXT genotype B,
and lanes 5–9 represent SXT genotype C. Numbers indicating
molecular sizes of bands correspond to 1-kb DNA ladder (BRL). the initiation of an epidemic is not clear. We speculate that
a critical factor for the recent reemergence of O139 vibrios
might have been the development of nalidixc acid resist-
ance. Identifying the first index case of the present cholera
epidemic is not possible. A spontaneous nalidixic
acid–resistant  V. cholerae O139 strain may have been
enriched in a patient undergoing nalidixc acid therapy,
leading to the eventual spread of the organism. This is cer-
tainly possible in view of the widespread use of nalidixic
acid in Bangladesh as a drug to treat other gastroenteritis,
including shigellosis. The emergence of V. cholerae O139
has received global attention not only as the first non–O1
V. cholerae capable of causing epidemic outbreaks but also
because of the rapid genetic re-assortment undergone by
strains of this new serogroup. Our study shows yet anoth-
er set of genetic and phenotypic changes in O139 vibrios
and their association with an epidemic of cholera in
Bangladesh. These results emphasize the need for continu-
ing molecular epidemiologic surveillance of V. cholerae in
Bangladesh and adjoining areas.
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